ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Safety"

  • 2015 American Transplant Congress

    Somatostatin (Eumedica®) Infusion Allows Modulating Graft Flows and Gradients in Liver Transplantation. Results of a Randomized, Double Blind, Placebo Controlled Trial

    R. Troisi,1 A. Croo,1 E. Codarin,3 E. De Wolf,1 J. Van Limmen,4 G. Antoniali,3 B. Heyse,4 L. De Baerdemaeker,4 I. Colle,5 G. Tell,3 M. Sainz-Barriga.1,2

    1General Hepatobiliary Surgery Liver Transplantation Service, Ghent University Hospital Medical School, Ghent, Belgium; 2Digestive Surgery & Liver Transplantation, University of Tours, Tours, France; 3Medical & Biological Sciences, University of Udine, Udine, Italy; 4Anesthesiology, Ghent University Hospital Medical School, Ghent, Belgium; 5Gastroenterology, Ghent University Hospital Medical School, Ghent, Belgium.

    Background: Somatostatin (SST) infusion decrease portal pressure in acute variceal bleeding in cirrhotic patients. Despite liver transplantation (LTx), recipients with portal hypertension (PHT) display different…
  • 2015 American Transplant Congress

    Belatacept in a Community Hospital Adult Kidney Transplant Program

    D. Nikolaenko, Q. Chaudhry, H. Smith, C. Shadur.

    Iowa Methodist Medical Center, Des Moines, IA.

    PURPOSE:This is a retrospective look (08/2011-11/2014) on data collected from patients transplanted at Iowa Methodist Transplant Center.METHODS:All patients were EBV positive. They were induced with…
  • 2015 American Transplant Congress

    Belatacept Treatment Through Home Infusion as a Safe and Reasonable Alternative to Intitution-Based Treatment: A Retrospective Analysis of Medical Records

    T. Kou,1 A. Deshmukh,1 J. Preston,1 A. Gomez,1 S. Rafanelli,2 K. Calderon.1

    1Bristol-Myers Squibb Company, Princeton, NJ; 2BiologicTx, Totowa, NJ.

    Purpose: Belatacept is a selective T-cell costimulation blocker indicated for prophylaxis of organ rejection in adult patients receiving a kidney transplant in combination with basiliximab…
  • 2015 American Transplant Congress

    Utility and Outcomes of Expanded Screening Among Live Solid Organ Donors

    A. Rosen, B. Ho, M. Ison.

    Organ Transplantation and Infectious Diseases, Northwestern University, Chicago.

    Background: The Organ Procurement Transplant Network (OPTN) now requires enhanced screening of selected live donors for Trypanosoma cruzi, Strongyloides stercoralis, Tuberculosis (TB), and West Nile…
  • 2015 American Transplant Congress

    Temporal Increase in the Incidence of Post-Transplantation Lymphoproliferative Disorder in Adult Renal Transplant Recipients: Analysis of 2 US Insurance Administrative Claims Databases

    T. Kou, H.-U. Meier-Kriesche, J. Preston, A. Gomez.

    Bristol-Myers Squibb Company, Princeton, NJ.

    Purpose: Post-transplant lymphoproliferative disorder (PTLD) is a serious complication after kidney transplant. In a prior analysis using Medicare claims database from 1995 to 2003, the…
  • 2015 American Transplant Congress

    Normothermic Machine Perfusion (NMP) on Discarded Human Livers: The First Model in the US

    Q. Liu, A. Nassar, G. Iuppa, D. Urcuyo-Llanes, D. Sexton, T. Okamoto, T. Uso, A. Bennett, W. Baldwin, K. Abu-Elmagd, J. Fung, C. Miller, C. Quintini.

    Cleveland Clinic, Cleveland, OH.

    The benefit of NMP preservation has been reported in a number of animal studies. Herein we describe safety, feasibility and effectiveness of NMP on discarded…
  • 2015 American Transplant Congress

    Pre-Transplant Cardiac Troponin T (cTT) Is a Strong Predictor of Post Kidney Transplant Hospitalizations

    H. Amer, P. Geerdes, T. Fettes, R. Walker, E. Lorenz, F. Cosio.

    The William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN.

    Identifying patients at risk of re-hospitalization will permit improved monitoring and may decrease morbidity.We examined nine objective variables at the time of transplant and their…
  • 2015 American Transplant Congress

    Efficacy and Safety of Three Different Treatment Regimen in De Novo Renal Transplant Patients: Month 48 Follow-Up Results of the HERAKLES Trial

    C. Sommerer,1 K. Budde,1 V. Kliem,1 O. Witzke,1 M. Guba,1 J. Jacobi,1 B. Vogt,3 I. Hauser,1 P. Reinke,1 R. Stahl,1 T. Rath,1 M. Porstner,2 D. Baeumer,2 M. Zeier,1 W. Arns,1 F. Lehner.1

    1Herakles Study Group, Germany; 2Novartis Pharma, Nuremberg, Germany; 3Herakles Study Group, Switzerland.

    Aim: To compare safety and efficacy of 3 different immunosuppressive (IS) regimen 4years after renal transplantation (Tx).Methods: 802 patients (pts) were included in this 1year,…
  • 2015 American Transplant Congress

    Interim Safety Experience in Transplant Patients Treated With Belatacept (Nulojix) in the Post-Approval Setting

    T. Kou, J. Braga, S. Sibabrata, J. Preston, M. Harler, A. Gomez.

    Bristol-Myers Squibb Company, Princeton, NJ.

    Purpose: Belatacept is a selective T-cell costimulation blocker indicated for prophylaxis of organ rejection in adult patients receiving a kidney transplant in combination with basiliximab…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences